Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Ethic and Genetics Pr. Didier LACOMBE Head Dept. Medical Genetics National Reference Center for Birth Defects CHU de Bordeaux Université Bordeaux 2 IV° French-Chinese Bioethics Conference Bordeaux 8-9/04/2010 Department of Medical Genetics Roles : diagnosis of a genetic disease And what’s around the diagnosis : - Care of the patient, familial support - Genetic counseling - Familial screening - Prenatal diagnosis - Presymtomatic diagnosis Medical Genetics = Family involvement Genetic Counseling Information of proband and family : * Disease characteristics : natural history, features, evolution, complications... * Heredity (mode of inheritance) * Recurence risk * Genetic testing possibilities * Screening and prenatal diagnosis possibilities Familial Screening • Screening for heterozygous status of recessive or X-linked conditions (mostly) • Affected child Familial cascade screening • Transmission of information via patient/family, not via doctors to concerned persons (avis 76 du comité consultatif national d’éthique pour les sciences de la vie et de la santé) • Information via Biomedical Agency (letter) ? Familial Screening • Informed free consent (Code de la Santé Publique Art. R1131-5) • No discrimination because of genetic characteristics (Code Civil - Art. 16-13) • No insurance or work implications, no obligation of genetic testing (Code de la Santé Publique - Art. 1141-1) Prenatal Diagnosis (PND) • Positive family history and gene mutation identified (~ 2000 disease-causing genes) • Risk → Knowledge (affected or not) • France: PND for severe and non treatable diseases at the time of diagnosis • Genetic counseling visite before PND (article L.2131-1 du code de la santé publique) • Final decision to parents for medical abortion Prenatal Diagnosis • In France PND via Multidisciplinary Centers agreed by Agence de Biomédecine • Medical abortion legal up to the end of the pregnancy • Decision from the couple • Psychological support Preimplantatory Diagnosis (PIP) • Genetic testing on 1/2 cells before uterus transfert of healthy embryos • Avoiding of potential medical abortion (MA) • Couples with multiples MAs • Indication of in vitro fecondation • PND/PIP: acceptability for late-onset genetic diseases ? (cancer predisposition …) Presymptomatic Diagnosis • Definition (P.Harper, 1997) = situations where an abnormal result indicates that the disease will almost develop at some point in life. • New Genetic Medicine: - High risk asymptomatic persons (~ 50%) for genetic disease - Late-onset disorders - Monogenic mendelian disorders Presymptomatic Diagnosis • Knowledge of genetic status of asymptomatic individuals at risk for developing an identified genetic disorder • Concerned persons : - at risk - adults - asymptomatic (absent features) - volontary consent Presymptomatic Diagnosis • Key notion of medical benefit • 2 different situations : • - Possible preventive/curative treatment (ex: cancer predisposition) • No preventive/curative treatment available (ex: neurodegenerative disorders) Model = Huntington disease Presymptomatic Diagnosis Ethical principles (WFN, Neurology, 1999) : • Benefit • Adulthood (independence) • Freedom • Engagement • Confidentiality • Equality • Right of not-knowing Presymptomatic Diagnosis • France (Décret 2000-570) : conditions of prescription of genetic testing • Multidisciplinary teams (Ministry of Health) HD: geneticist, neurologist, psychologist • Care and testing (4-6 months) protocols • Illegal in children without medical benefit Presymptomatic Diagnosis Justifications • • • • • To relieve uncertainly about genetic status To plan a family To plan for the future To inform the children To be sure one is carrier 54 % 14 % 13 % 14 % 2% Presymptomatic Diagnosis Remarkable events • Pregnancy (50 % PND; 50 % MA) 20 % • Serious adverse events: - Psychological distress and depression 9 % - Psychiatric hospitalization 2% - Suicide attempt 0% Presymptomatic Diagnosis Conclusions • New concept • Molecular genetic advances : activity • 2 care levels: - Severe diseases : HD model SCA, hereditary dementia/Alzheimer - Mild diseases : CMT, FSH, myotonic dystrophy Genetic Testing in Children • Information, free choice, consent : not possible in children, choice of the parents • Possible in symptomatic children (CF, DMD ..) • Possible: medical benefit in asymptomatic child: - curative/preventive treatment: cancer predisposition syndromes (APC, Gorlin …) - screening/follow-up (Steinert, glaucoma …) - professional/social orientation (CM, CMT …) Genetic Testing in Children Genetic tests forbidden in asymptomatic child : • Severe late-onset genetic disorders - Hereditary cancer predisposition (BRCA1, BRCA2, HNPCC …) - Neurodegerative late-onset diseases (HD, SCA, CADASIL …) • Recessive heterozygous status • Multigenic/polyfactorial heredity Genetic Testing in Children • Personal benefit for the child • Preventive/curative treatment for the family • Deprivation of the right of not-knowing • Breakdown in the child-parents relationship • Disease anticipation Prescription of genetic testing: Difficulties • Lack of specific information before clinical use (genetic counseling) • Random genetic predisposition identification (CGH-array and cancer predisposition) • Presymptomatic testing • Minor children • No individual medical follow-up Free access to genetic testing (autotests via internet) • No medical follow-up (indication, interpretation ..) • No medical indication/interest • No ethic or juridic guide (identity, consent, child ..) • No technical guide (fiability, quality ..)